Skip to content

Clinical study on the treatment of cough variant asthma of liver-fire invading lung type by adding Chaiqinzhijie decoction

Clinical study on the treatment of cough variant asthma of liver-fire invading lung type by adding Chaiqinzhijie decoction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003906
Enrollment
Unknown
Registered
2020-09-08
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough variant asthma

Interventions

Sponsors

The Second Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of cough variant asthma and TCM syndrome. 2. The patient's age was > 18 years old and < 65 years old, and the course of disease was more than 6 weeks. 3. Not taking drugs or taking the drugs specified in the guidelines for diagnosis and treatment of cough (2015); 4. The patients who had taken traditional Chinese medicine for CVA were observed after two weeks of withdrawal; 5. After stopping inhaling glucocorticoids, bronchodilators and other drugs to reduce airway hyperresponsiveness, the patients with positive bronchodilation test and cough as the main symptoms were detected 24 hours later; 6. Patients who are willing to cooperate with this clinical study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Typical asthma, esophageal reflux disease, pharyngitis, etc. 2. Pregnant or lactating women, or patients who are allergic to the drug in this study. 3. Patients with mental disorders, behavioral disorders, or severe hearing problems and who are considered to be impaired or illiterate and unable to cooperate. 4. Patients with severe pulmonary heart disease, respiratory failure or other serious organ dysfunction. 5. Patients who have used other Chinese and Western medicines for cough treatment or are participating in clinical research of other drugs after the onset of the disease. 6. Patients with poor compliance with traditional Chinese and Western medicine treatment.

Design outcomes

Primary

MeasureTime frame
Pulmonary Function;Pulmonary Function;

Countries

China

Contacts

Public ContactTongmao Zhang

The Second Hospital of Tianjin Medical University

13602116692@163.com+86 18602611503

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026